In the first one, aimed to assess whether dual inhibition of G9a and DNMT1 affected tumor growth and metabolic uptake, we used immunocompromised mice, where A549 cells were subcutaneously injected (Fig. 3A–D). Here, DNMT1 is linked to neoplasm.